Front Row Advisors’s Relmada Therapeutics RLMD Stock Holding History

Front Row Advisors’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2	Sell
2025 Q1	$2	Buy
2024 Q4	–	Sell
2024 Q3	$19	Hold
2024 Q2	$18	Hold
2024 Q1	$28	Hold
2023 Q4	$25	Hold
2023 Q3	$18	Hold
2023 Q2	$0	Hold
2023 Q1	$0	Buy